GEN Exclusives

More »

GEN News Highlights

More »
Sep 10, 2007

AMRI’s $8M R&D Facility in India Opened

  • AMRI opened its $8 million, 50,000 sq. ft. R&D center in Hyderabad, India. The facility includes laboratories for conducting early-stage research such as custom chemical synthesis and analytical chemistry.

    During this first phase of expansion, the R&D building will add approximately 100 employees to AMRI’s operations at this location, which currently has 35 scientists. The company reports that infrastructure is in place that will allow it to add a second facility, which would more than double employee headcount.

    Also, scale-up laboratories for preparing both preclinical and clinical trial supply active ingredients are expected to open later this year and 2008, respectively, according to AMRI.

    AMRI states that the opening marks another milestone in the company’s global expansion. In May, AMRI acquired two pharmaceutical manufacturing sites, along with additional land for expansion, in Aurangabad and Navi Mumbai, India. “We look forward to achieving synergies between these new development laboratories and our large-scale manufacturing facilities,” remarks Thomas E. D’Ambra, Ph.D., chairman, CEO, and president.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Alzheimer's Therapies

Do you think an effective treatment for Alzheimer’s will be found within the next 10–15 years?